Description: The peptide is used to block Anti-TGFBR2 Antibody (#CPA5062) reactivity. Form: Lyophilized powder Gene Symbol: TGFBR2 Alternative Names: TGF-beta receptor type-2; TGFR-2; TGF-beta type II receptor; Transforming growth factor-beta receptor type II; TGF-beta receptor type II; TbetaR-IIEntrez Gene (Human): 7048Entrez Gene (Mouse) : 21813Entrez Gene (Rat) : 81810SwissProt (Human): P37173SwissProt (Mouse) : Q62312SwissProt (Rat) : P38438Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.

• 
  Western blot analysis of TGFBR2 expression in A549 (A), NIH3T3 (B) whole cell lysates.
• 
  Immunohistochemical analysis of TGFBR2 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.